MINNEAPOLIS, MINNESOTA -- (Marketwired) -- 03/17/17 -- DiaMedica Therapeutics Inc. (the "Company") (TSX VENTURE: DMA)(OTCQB: DMCAF) today announces that the Board of Directors has granted options to purchase 300,000 common shares of the Corporation to the Company''s management at an exerc ...
↧